Immediate Impact
61 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Jean Torrisi being referenced
Abstract PR02: Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jean Torrisi | 68 | 88 | 120 | 11 | 297 | |
| Benjamin Bonhomme | 44 | 78 | 125 | 15 | 249 | |
| Jacques Cretin | 44 | 85 | 167 | 9 | 324 | |
| Napapat Amornwichet | 116 | 93 | 73 | 18 | 326 | |
| Ying‐Yang Liao | 73 | 54 | 95 | 15 | 299 | |
| Lei Yu | 68 | 61 | 77 | 10 | 246 | |
| G. Atalay | 63 | 67 | 177 | 12 | 309 | |
| Amy Guppy | 80 | 38 | 102 | 10 | 293 | |
| I D H Todd | 49 | 63 | 133 | 10 | 309 | |
| Douglas G. Gold | 27 | 136 | 95 | 10 | 315 | |
| Yi Zhang | 23 | 85 | 212 | 13 | 290 |
All Works
Login with ORCID to disown or claim papers
Loading papers...